𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Age at infection, gender and viral genotype affect rate of fibrosis in hepatitis C virus infection

✍ Scribed by Mark Wright; Robert Goldin; Howard Thomas; Mark Thursz

Book ID
118565408
Publisher
Elsevier Science
Year
2002
Tongue
English
Weight
109 KB
Volume
36
Category
Article
ISSN
0168-8278

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Genotype distribution of hepatitis C vir
Genotype distribution of hepatitis C virus infection in Taiwan
✍ Jau-Shin Wu; Han-Fang Lee; Hui-Ling Hsiau; Hsiu-Ying Lu; Wen-Hsiang Chou; Chih-F πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 English βš– 642 KB

## Abstract To investigate the prevalence of genotype distribution of hepatitis C virus (HCV) infection in Taiwan, genotypes were identified in 122 (36 anti‐HCV‐positive blood donors, 44 anti‐HCV‐positive aborigines, 28 hemodialysis patients, and 14 patients with chronic liver diseases) of 280 subj

Viral Dynamics in Hepatitis B Virus Infe
Viral Dynamics in Hepatitis B Virus Infection
✍ Martin A. Nowak, Sebastian Bonhoeffer, Andrew M. Hill, Richard Boehme, Howard C. πŸ“‚ Article πŸ“… 1996 πŸ› National Academy of Sciences 🌐 English βš– 852 KB
An update on treatment of hepatitis C vi
An update on treatment of hepatitis C virus genotype 1 infection and viral load assessments
✍ Bryan Cobb; Regis A. Vilchez πŸ“‚ Article πŸ“… 2012 πŸ› John Wiley and Sons 🌐 English βš– 724 KB

According to the recently released American Association for the Study of Liver Diseases (AASLD) guidelines for the treatment of hepatitis C virus (HCV) genotype 1 chronic infection, 1 in treatment-naΔ± Β¨ve subjects the association of boceprevir or telaprevir with peginterferon-alpha and ribavirin is

High rate of spontaneous clearance of ac
High rate of spontaneous clearance of acute hepatitis C virus genotype 3 infection
✍ Marc Lehmann; Manuela F. Meyer; Masyar Monazahian; Hans L. Tillmann; Michael P. πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 81 KB

## Abstract Treating acute hepatitis C with interferon alpha prevents chronicity in nearly all cases when therapy is initiated within 3 months after infection. However, 15–50% of untreated patients may clear the hepatitis C virus (HCV) spontaneously. Therefore, factors are needed to identify patien